Innovative therapies for children with cancer
European Proof-of-Concept Therapeutic Stratification Trial on Molecular Anomalies in Relapsed or Refractory Tumors in children (AcSé-ESMART)
2020
FRANCE
Soutien à une étude intitulée ‘European Proof-of-Concept Therapeutic Stratification Trial on Molecular Anomalies in Relapsed or Refractory Tumors in children (AcSé-ESMART)’.